Pharmaceutical Protein Drug Development
Course, Master's level, 3FB031
Spring 2024 Spring 2024, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 15 January 2024–15 February 2024
- Language of instruction
- English
- Entry requirements
-
150 credits, including 90 credits in biomedicine, pharmaceutical science, chemistry, natural science and/or engineering, and Biological Drugs, 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 16 October 2023
- Application code
- UU-89219
Admitted or on the waiting list?
- Registration period
- 8 January 2024–15 January 2024
- Information on registration from the department
Spring 2025 Spring 2025, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 20 January 2025–20 February 2025
- Language of instruction
- English
- Entry requirements
-
150 credits, including 90 credits in biomedicine, pharmaceutical science, chemistry, natural science and/or engineering, and Biological Drugs, 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 October 2024
- Application code
- UU-89219
Admitted or on the waiting list?
About the course
Through the course, you will gain an understanding of how to further develop a protein-based biological drug after the initial proposed design of the drug. You will work on designing experiments to analyse if the biological drug has the predicted effect as well as in-depth formulate which indication you should treat and which diagnostic tools can be used to find the right patient group. They will also develop a target products profile (TPP) for the drug candidate and based on this formulate a quality TPP. With this base, they will learn more about analytical tools that can be used during the process development of a drug and also gain an understanding of how the drug and/or its effects can be measured in biological samples by e.g. mass spectrometry.
Reading list
No reading list found.